Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rarefied Biosciences is an Australian biotechnology company focused on the discovery and development of novel therapeutics for rare and neglected diseases. The company utilizes a proprietary discovery platform that integrates advanced computational modeling with high-throughput screening to identify small molecule candidates for challenging biological targets. Their primary mission is to address significant unmet medical needs in patient populations that are often overlooked by traditional pharmaceutical development. Rarefied Biosciences maintains a lean operational model, leveraging strategic partnerships with academic institutions and contract research organizations to advance its early-stage pipeline. The company is currently focused on optimizing lead candidates within its metabolic and rare disease programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rarefied Biosciences Australia.